Skip to main content

Institutional Biosafety Committee

Medical Background with Various Cells

The Institutional Biosafety Committee (IBC) oversees all research involving biological materials including some molecules, bacteria, viruses, arthropods and recombinant DNA technology in accordance with guidance from the National Institutes of Health (NIH). In addition, if you are creating transgenic lines of organisms as research models, they could require approval from IBC.

Next IBC Meeting: November 4, 2024 - 10:00am

For location information, contact the IBC

  • Erica Martin – Senior Compliance Specialist           

            610-519-4226

            610-519-4250

  • Nicole Jacobs- Interim Director                                        

       For general inquiries, contact the Office of Research Protections

 

To report compliance issues, call EthicsPoint Hotline toll free 1-955-236-1443.